Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chow, H-H. S.
Right arrow Articles by Alberts, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, H-H. S.
Right arrow Articles by Alberts, D. S.
Related Collections
Right arrow Clinical Intervention
Right arrow Clinical Intervention: Diet and Diet-related Factors
Right arrow Clinical Intervention: Early-Phase (I/II) Clinical or Translational Trials
Clinical Cancer Research Vol. 11, 4627-4633, June 15, 2005
© 2005 American Association for Cancer Research


Cancer Prevention

Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals

H-H. Sherry Chow1, Iman A. Hakim1, Donna R. Vining1, James A. Crowell2, James Ranger-Moore1, Wade M. Chew1, Catherine A. Celaya1, Steven R. Rodney1, Yukihiko Hara3 and David S. Alberts1

Authors' Affiliations: 1 Arizona Cancer Center, The University of Arizona, Tucson, Arizona; 2 Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; and 3 Mitsui Norin Co., Ltd., Shizuoka, Japan

Requests for reprints: H-H. Sherry Chow, Arizona Cancer Center, The University of Arizona, Tucson, AZ 85724. Phone: 520-626-3358; Fax: 520-626-5348; E-mail: schow{at}azcc.arizona.edu.

Purpose: Green tea has been shown to exhibit cancer-preventive activities in preclinical studies. Its consumption has been associated with decreased risk of certain types of cancers in humans. The oral bioavailability of the major green tea constituents, green tea catechins, is low, resulting in systemic catechin levels in humans many fold less than the effective concentrations determined in in vitro systems. We conducted this clinical study to test the hypothesis that the oral bioavailability of green tea catechins can be enhanced when consumed in the absence of food.

Experimental Designs: Thirty healthy volunteers were randomly assigned to one of the following doses of Polyphenon E (a decaffeinated and defined green tea catechin mixture): 400, 800, or 1,200 mg, based on the epigallocatechin gallate content (10 subjects per dose group). After an overnight fast, study participants took a single dose of Polyphenon E with or without a light breakfast, which consisted of one or two 4-oz muffins and a glass of water. Following a 1-week wash-out period, subjects were crossed over to take the same dose of Polyphenon E under the opposite fasting/fed condition. Tea catechin concentrations in plasma and urine samples collected after dosing were determined by high-pressure liquid chromatography analysis.

Results: Consistent with previous reports, epigallocatechin gallate and epicatechin gallate were present in plasma mostly as the free form, whereas epicatechin and epigallocatechin were mostly present as the glucuronide and sulfate conjugates. There was >3.5-fold increase in the average maximum plasma concentration of free epigallocatechin gallate when Polyphenon E was taken in the fasting condition than when taken with food. The dosing condition led to a similar change in plasma-free epigallocatechin and epicatechin gallate levels. Taking Polyphenon E in the fasting state did not have a significant effect on the plasma levels of total (free and conjugated) epigallocatechin, but resulted in lower plasma levels of total epicatechin. Urinary epigallocatechin gallate and epicatechin gallate levels were very low or undetectable following Polyphenon E administration with either dosing condition. Taking Polyphenon E under the fasting state resulted in a significant decrease in the urinary recovery of total epigallocatechin and epicatechin. Polyphenon E administered as a single dose over the dose range studied was generally well-tolerated by the study participants. Mild and transient nausea was noted in some of the study participants and was seen most often at the highest study agent dose (1,200 mg epigallocatechin gallate) and in the fasting condition.

Conclusions: We conclude that greater oral bioavailability of free catechins can be achieved by taking the Polyphenon E capsules on an empty stomach after an overnight fast. Polyphenon E up to a dose that contains 800 mg epigallocatechin gallate is well-tolerated when taken under the fasting condition. This dosing condition is also expected to optimize the biological effects of tea catechins.

Key Words: Oral bioavailability • Green tea catechins • Food effect • Doing condition




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. W. Anderson, C. Goodin, Y. Zhang, S. Kim, R. D. Estensen, T. S. Wiedmann, P. Sekar, C. R. Buncher, J. C. Khoury, J. R. Garbow, et al.
Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice
Carcinogenesis, August 1, 2008; 29(8): 1594 - 1600.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. M. Henning, J. J. Choo, and D. Heber
Nongallated Compared with Gallated Flavan-3-ols in Green and Black Tea Are More Bioavailable
J. Nutr., August 1, 2008; 138(8): 1529S - 1534S.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
C. E. Isaacs, G. Y. Wen, W. Xu, J. H. Jia, L. Rohan, C. Corbo, V. Di Maggio, E. C. Jenkins Jr., and S. Hillier
Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus
Antimicrob. Agents Chemother., March 1, 2008; 52(3): 962 - 970.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. R. Khuri and D. M. Shin
Head and Neck Cancer Chemoprevention Gets a Shot in the Arm
J. Clin. Oncol., January 20, 2008; 26(3): 345 - 347.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H.-H. S. Chow, I. A. Hakim, D. R. Vining, J. A. Crowell, M. E. Tome, J. Ranger-Moore, C. A. Cordova, D. M. Mikhael, M. M. Briehl, and D. S. Alberts
Modulation of Human Glutathione S-Transferases by Polyphenon E Intervention
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1662 - 1666.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. H. Kang, J. H. Lee, C. K. Song, H. D. Han, B. C. Shin, S. I. Pai, C.-F. Hung, C. Trimble, J.-S. Lim, T. W. Kim, et al.
Epigallocatechin-3-Gallate Enhances CD8+ T Cell-Mediated Antitumor Immunity Induced by DNA Vaccination
Cancer Res., January 15, 2007; 67(2): 802 - 811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H-H. S. Chow, I. A. Hakim, D. R. Vining, J. A. Crowell, C. A. Cordova, W. M. Chew, M.-J. Xu, C.-H. Hsu, J. Ranger-Moore, and D. S. Alberts
Effects of Repeated Green Tea Catechin Administration on Human Cytochrome P450 Activity
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2473 - 2476.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.